M Bentz Selected Research

M Bentz Research Topics

5	Neoplasms (Cancer) 01/2003 - 03/2000
4	Lymphoma (Lymphomas) 03/2008 - 04/2000
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2017
2	Infections 01/2017 - 03/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2017
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2012
1	Leukopenia 03/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2008
1	Thrombocytopenia (Thrombopenia) 03/2008
1	Acute Kidney Injury (Acute Renal Failure) 02/2003
1	Hemolytic-Uremic Syndrome 02/2003
1	Thrombosis (Thrombus) 02/2003
1	Breast Neoplasms (Breast Cancer) 07/2001
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2001
1	Neoplasm Metastasis (Metastasis) 02/2001
1	Leukemia 10/2000
1	Body Weight (Weight, Body) 09/2000
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 08/2000
1	Disease Progression 04/2000
1	Meningitis 02/2000

3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 01/2017
2	Rituximab (Mabthera)FDA Link 10/2012 - 03/2008
2	Etoposide (VP 16)FDA LinkGeneric 03/2008 - 03/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2008 - 03/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2008 - 03/2008
2	DNA (Deoxyribonucleic Acid)IBA 06/2003 - 10/2000
2	ParaffinIBA 07/2001 - 02/2001
2	DNA ProbesIBA 04/2001 - 03/2000
2	Proteins (Proteins, Gene)FDA Link 09/2000 - 08/2000
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023
1	fludarabineIBA 12/2017
1	Imatinib Mesylate (Gleevec)FDA Link 11/2017
1	InterferonsIBA 11/2017
1	pegfilgrastim (Neulasta)FDA Link 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Prednisone (Sone)FDA LinkGeneric 03/2008
1	Vincristine (Oncovin)FDA LinkGeneric 03/2008
1	Shiga Toxins (Vero Toxin)IBA 02/2003
1	Shiga Toxin (Shigella Toxin)IBA 02/2003
1	Complementary DNA (cDNA)IBA 01/2003
1	Estrogen ReceptorsIBA 07/2001
1	XenobioticsIBA 09/2000
1	DioxinsIBA 09/2000
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 09/2000
1	NF-kappa B (NF-kB)IBA 08/2000
1	Granzymes (Granzyme)IBA 04/2000
1	Antineoplastic Agents (Antineoplastics)IBA 04/2000
1	PerforinIBA 04/2000
1	AntigensIBA 04/2000
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 02/2000

3	Drug Therapy (Chemotherapy) 01/2023 - 03/2008
2	Therapeutics 01/2017 - 03/2008
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 03/2008
1	Mohs Surgery (Mohs' Micrographic Surgery) 02/2001
1	Aftercare (After-Treatment) 02/2001